Curio Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-748
Closed -$95.5K 1178
2026
Q1
$95.5K Hold
748
0.03% 103
2025
Q4
$94.5K Hold
748
0.03% 106
2025
Q3
$75K Hold
748
0.03% 107
2025
Q2
$62K Buy
748
+747
+74,700% +$59.6K 0.03% 119
2025
Q1
$67.4K Sell
1
-747
-100% -$66.8K 0.04% 114
2024
Q4
$67.4K Buy
+748
New +$72.5K 0.04% 112

Other funds holding XBI

Curio Wealth's XBI Position: Q2 2026 in Review

Curio Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 748 shares — an estimated $95.5K sold.

Curio Wealth first reported a position in XBI in Q4 2024 and held it in 6 quarters. The position peaked at $95.5K in Q1 2026. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Curio Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
  • Curio Wealth sold 748 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $95.5K.
  • Curio Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and held it in 6 quarters.
  • Curio Wealth's State Street SPDR S&P Biotech ETF position peaked at $95.5K in Q1 2026.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.